BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21666721)

  • 1. Modulation of Wnt/β-catenin signaling and proliferation by a ferrous iron chelator with therapeutic efficacy in genetically engineered mouse models of cancer.
    Coombs GS; Schmitt AA; Canning CA; Alok A; Low IC; Banerjee N; Kaur S; Utomo V; Jones CM; Pervaiz S; Toone EJ; Virshup DM
    Oncogene; 2012 Jan; 31(2):213-25. PubMed ID: 21666721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling.
    Yamada K; Hori Y; Inoue S; Yamamoto Y; Iso K; Kamiyama H; Yamaguchi A; Kimura T; Uesugi M; Ito J; Matsuki M; Nakamoto K; Harada H; Yoneda N; Takemura A; Kushida I; Wakayama N; Kubara K; Kato Y; Semba T; Yokoi A; Matsukura M; Odagami T; Iwata M; Tsuruoka A; Uenaka T; Matsui J; Matsushima T; Nomoto K; Kouji H; Owa T; Funahashi Y; Ozawa Y
    Cancer Res; 2021 Feb; 81(4):1052-1062. PubMed ID: 33408116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades.
    Katoh M; Katoh M
    Cancer Biol Ther; 2006 Sep; 5(9):1059-64. PubMed ID: 16940750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt inhibitor screen reveals iron dependence of β-catenin signaling in cancers.
    Song S; Christova T; Perusini S; Alizadeh S; Bao RY; Miller BW; Hurren R; Jitkova Y; Gronda M; Isaac M; Joseph B; Subramaniam R; Aman A; Chau A; Hogge DE; Weir SJ; Kasper J; Schimmer AD; Al-awar R; Wrana JL; Attisano L
    Cancer Res; 2011 Dec; 71(24):7628-39. PubMed ID: 22009536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt5a suppresses tumor formation and redirects tumor phenotype in MMTV-Wnt1 tumors.
    Easter SL; Mitchell EH; Baxley SE; Desmond R; Frost AR; Serra R
    PLoS One; 2014; 9(11):e113247. PubMed ID: 25401739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer.
    Prosperi JR; Goss KH
    Curr Drug Targets; 2010 Sep; 11(9):1074-88. PubMed ID: 20545611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the Wnt/β-catenin signaling pathway in human cancers.
    Yao H; Ashihara E; Maekawa T
    Expert Opin Ther Targets; 2011 Jul; 15(7):873-87. PubMed ID: 21486121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MMTV-Wnt1 and -DeltaN89beta-catenin induce canonical signaling in distinct progenitors and differentially activate Hedgehog signaling within mammary tumors.
    Teissedre B; Pinderhughes A; Incassati A; Hatsell SJ; Hiremath M; Cowin P
    PLoS One; 2009; 4(2):e4537. PubMed ID: 19225568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
    Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
    Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies.
    Ettenberg SA; Charlat O; Daley MP; Liu S; Vincent KJ; Stuart DD; Schuller AG; Yuan J; Ospina B; Green J; Yu Q; Walsh R; Li S; Schmitz R; Heine H; Bilic S; Ostrom L; Mosher R; Hartlepp KF; Zhu Z; Fawell S; Yao YM; Stover D; Finan PM; Porter JA; Sellers WR; Klagge IM; Cong F
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15473-8. PubMed ID: 20713706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity.
    Maric G; Annis MG; MacDonald PA; Russo C; Perkins D; Siwak DR; Mills GB; Siegel PM
    Oncogene; 2019 Jun; 38(26):5294-5307. PubMed ID: 30914799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for iron in Wnt signalling.
    Brookes MJ; Boult J; Roberts K; Cooper BT; Hotchin NA; Matthews G; Iqbal T; Tselepis C
    Oncogene; 2008 Feb; 27(7):966-75. PubMed ID: 17700530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active β-catenin.
    Lavergne E; Hendaoui I; Coulouarn C; Ribault C; Leseur J; Eliat PA; Mebarki S; Corlu A; Clément B; Musso O
    Oncogene; 2011 Jan; 30(4):423-33. PubMed ID: 20856206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive feedback regulation between phospholipase D and Wnt signaling promotes Wnt-driven anchorage-independent growth of colorectal cancer cells.
    Kang DW; Min do S
    PLoS One; 2010 Aug; 5(8):e12109. PubMed ID: 20711340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferation.
    Lu W; Tinsley HN; Keeton A; Qu Z; Piazza GA; Li Y
    Eur J Pharmacol; 2009 Jan; 602(1):8-14. PubMed ID: 19026633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Wnt signaling activity for growth suppression induced by quercetin in 4T1 murine mammary cancer cells.
    Kim H; Seo EM; Sharma AR; Ganbold B; Park J; Sharma G; Kang YH; Song DK; Lee SS; Nam JS
    Int J Oncol; 2013 Oct; 43(4):1319-25. PubMed ID: 23900432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.
    Hallett RM; Kondratyev MK; Giacomelli AO; Nixon AM; Girgis-Gabardo A; Ilieva D; Hassell JA
    PLoS One; 2012; 7(3):e33976. PubMed ID: 22470504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma.
    Kamihara Y; Takada K; Sato T; Kawano Y; Murase K; Arihara Y; Kikuchi S; Hayasaka N; Usami M; Iyama S; Miyanishi K; Sato Y; Kobune M; Kato J
    Oncotarget; 2016 Sep; 7(39):64330-64341. PubMed ID: 27602957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A diterpenoid derivative 15-oxospiramilactone inhibits Wnt/β-catenin signaling and colon cancer cell tumorigenesis.
    Wang W; Liu H; Wang S; Hao X; Li L
    Cell Res; 2011 May; 21(5):730-40. PubMed ID: 21321609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation status of Wnt/ß-catenin signaling in normal and neoplastic breast tissues: relationship to HER2/neu expression in human and mouse.
    Khalil S; Tan GA; Giri DD; Zhou XK; Howe LR
    PLoS One; 2012; 7(3):e33421. PubMed ID: 22457761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.